Newsletter DTU

BioTrends Newsletter

Bjarke Bak Christensen, Head of DTU Bioengineering.

DTU’s new National Biologics Facility (NBF) brings DTU into the world league of CHO cell line engineering. Faster development of biological drugs and treatments is one of the goals of NBF, and the facility will benefit small and medium-sized enterprises, as they can to draw on our services in their work with identifying and developing new drug candidates.

From DTU’s point of view, it is also wonderful that NBF is making it possible to establish new study programmes within CHO cell line engineering.

DTU expands research and collaboration on cell cultures

Danish research into cell cultures and the development of proteins for biological pharmaceuticals—including for cancer treatment—is strengthened with new unit at DTU. Read more


		Gut bacteria predict weight loss A new study shows that gut bacteria play a greater role in weight loss than diet and genetics combined. Read more
		New unique imaging facility at DTU The facility is a major step on the road to targeted use of microbiomes for biological control of disease-causing organisms. Read more
		National cluster for life science and welfare technology goes live The newly formed cluster will contribute to and improve the foundation for world-class patient care, innovation and product development. Read more
		DKK 25 M to develop recombinant snakebite antivenom A grant of DKK 25 M from Wellcome gives hope to snakebite victims in sub-Saharan Africa of better and safer treatment. Read more
		New knowledge about coliforms to counteract multi-resistance Researchers have now mapped how coliform bacteria attach to the intestinal wall giving hope for development of new treatments. Read more